Department of Family Medicine, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung, Taiwan; Graduate Institute of Chinese Medicine, School of Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung, Taiwan.
International Master Program in Acupuncture, College of Chinese Medicine, China Medical University, Taichung, Taiwan; Department of Chinese Medicine, China Medical University Hospital, Taichung, Taiwan.
Ageing Res Rev. 2022 Dec;82:101747. doi: 10.1016/j.arr.2022.101747. Epub 2022 Oct 9.
The potential role of Tai Chi in improving sarcopenia and frailty has been shown in randomized controlled trials (RCTs). This systematic review and meta-analysis aimed to examine the effect of Tai Chi on muscle mass, muscle strength, physical function, and other geriatric syndromes in elderly individuals with sarcopenia and frailty.
Systematic searches of the PubMed, Cochrane Library, PEDro, EMBASE, Web of Science, CINAHL, and Medline databases for RCTs published between 1989 and 2022 were conducted; the database searchers were supplemented with manual reference searches. The inclusion criteria were as follows: (1) the study was designed as a RCT; (2) Tai Chi was one of the intervention arms; (3) the participants had a minimum age of ≥ 60 years and were diagnosed with frailty or sarcopenia, and the diagnostic guidelines or criteria were mentioned; (4) the number of participants in each arm was ≥ 10; and (5) the outcome reports included ≥ 1 item from the following primary or secondary outcomes. The exclusion criteria were as follows: (1) non-RCT studies; (2) nonhuman subjects; (3) participants aged < 60 years; (4) no description of the diagnostic guidelines or criteria for frailty or sarcopenia in the text; and (5) reported outcomes not among the following primary or secondary outcomes. The primary outcomes were muscle mass, grip strength and muscle performance (gait speed, 30-second chair stand test (30CST), sit-to-stand test (SST), Timed up and go test (TUGT), balance, and the Short Physical Performance Battery (SPPB)). The secondary outcomes included the number of falls and fear of falling (FOF), diastolic blood pressure (DBP), Mini-Mental State Examination (MMSE) score, and depression and quality of life (QOL) assessments.
Eleven RCTs were conducted from 1996 to 2022 in 5 countries that investigated 1676 sarcopenic or frail elderly individuals were included in the review. There were 804 participants in the Tai Chi exercise cohort and 872 participants in the control cohort (nonexercised (n = 5)/ exercise (n = 8)). The mean age of participants was 70-89.5 years and the numbers of participants from each arm in each study were 10-158. The majority of the participants practiced Yang-style Tai Chi (n = 9), and the numbers of movement ranged from 6 to 24. The prescriptions of training were 8-48 weeks, 2-7 sessions per weeks, and 30-90 min per session. Most studies used Tai Chi expert as instructor (n = 8). The lengths of follow-up period were 8-48 weeks. The results from our meta-analysis revealed significant improvements for Tai Chi compared to control group (nonexercise/ exercise) on measures of the 30CST (weighted mean difference (WMD): 2.36, 95% confidence interval (CI) 1.50-3.21, p < 0.00001, I = 87%), the TUGT (WMD: -0.72, 95% CI -1.10 to -0.34, p = 0.0002, I =0%), numbers of fall (WMD: -0.41, 95% CI -0.64 to -0.17, p = 0.0006, I =0%) and FOF (standardized MD (SMD): -0.50, 95% CI -0.79 to -0.22, p = 0.0006, I = 57%); and for Tai Chi compared to 'nonexercise' controls on measures of SST (WMD: -2.20, 95% CI -2.22 to -2.18, p < 0.00001), balance (SMD: 9.85, 95% CI 8.88-10.82, p < 0.00001), DBP (WMD: -7.00, 95% CI -7.35 to -6.65, p < 0.00001), MMSE (WMD: 1.91, 95% CI 1.73-2.09, p < 0.00001, I =0%), depression (SMD: -1.37, 95% CI -1.91 to -0.83, p < 0.00001) and QOL (SMD: 10.72, 95% CI 9.38-12.07, p < 0.00001). There were no significant differences between Tai Chi and control groups on any of the remaining 4 comparisons: body muscle mass (WMD: 0.53, 95% CI -0.18 to 1.24; P = 0.14; I =0%), grip strength (WMD: -0.06, 95% CI -1.98 to 1.86; P = 0.95; I =0%), gait speed (WMD: 0.05, 95% CI -0.11 to 0.20; P = 0.55; I =99%), and SPPB (WMD: 0.55, 95% CI -0.04 to 1.14; P = 0.07). The variables of bias summary, Tai Chi instructor, Tai Chi movements, and Tai Chi training duration without significant association with the 30CST or the TUGT through meta-regression analyses.
Our results demonstrated that patients with frailty or sarcopenia who practiced Tai Chi exhibited improved physical performance in the 30-second chair stand test, the Timed up and go test, number of falls and fear of falling. However, there was no difference in muscle mass, grip strength, gait speed, or Short Physical Performance Battery score between the Tai Chi and control groups. Improvements in the sit-to-stand test, balance, diastolic blood pressure, Mini-Mental State Examination score, and depression and quality of life assessments were found when comparing the Tai Chi cohort to the nonexercise control cohort rather than the exercise control cohort. To explore the effectiveness of Tai Chi in sarcopenic and frail elderly individuals more comprehensively, a standardized Tai Chi training prescription and a detailed description of the study design are suggested for future studies.
随机对照试验(RCTs)已显示太极拳在改善肌少症和衰弱方面的潜在作用。本系统评价和荟萃分析旨在研究太极拳对老年人肌少症和衰弱患者的肌肉质量、肌肉力量、身体功能和其他老年综合征的影响。
系统检索了 1989 年至 2022 年间发表的 PubMed、Cochrane 图书馆、PEDro、EMBASE、Web of Science、CINAHL 和 Medline 数据库中的 RCTs,并通过手动参考文献搜索进行了补充。纳入标准如下:(1)研究设计为 RCT;(2)太极拳为干预组之一;(3)参与者的最小年龄≥60 岁,被诊断为衰弱或肌少症,并且提到了诊断指南或标准;(4)每组参与者≥10 人;(5)报告的结果至少包含以下主要或次要结果之一。排除标准为:(1)非 RCT 研究;(2)非人类受试者;(3)参与者年龄<60 岁;(4)文本中未描述衰弱或肌少症的诊断指南或标准;(5)报告的结果不属于以下主要或次要结果。主要结果为肌肉质量、握力和肌肉表现(步态速度、30 秒椅子站立测试(30CST)、坐站测试(SST)、起身行走测试(TUGT)、平衡和简短体能测试(SPPB))。次要结果包括跌倒和跌倒恐惧(FOF)次数、舒张压(DBP)、简易精神状态检查(MMSE)评分、抑郁和生活质量(QOL)评估。
从 1996 年到 2022 年,在 5 个国家进行了 11 项 RCT,共纳入 1676 名肌少症或衰弱的老年患者。共有 804 名参与者参加了太极拳锻炼组,872 名参与者参加了对照组(无运动组[ n = 5])/运动组[ n = 8])。参与者的平均年龄为 70-89.5 岁,每项研究每组参与者人数为 10-158 人。大多数参与者练习杨式太极拳( n = 9),动作次数从 6 次到 24 次不等。训练处方为 8-48 周,每周 2-7 次,每次 30-90 分钟。大多数研究都使用太极拳专家作为指导员( n = 8)。随访时间为 8-48 周。我们的荟萃分析结果显示,与对照组(无运动/运动)相比,太极拳在 30CST(加权均数差(WMD):2.36,95%置信区间(CI)1.50-3.21, p < 0.00001,I = 87%)、TUGT(WMD:-0.72,95% CI -1.10 至-0.34, p = 0.02,I = 0%)、跌倒次数(WMD:-0.41,95% CI -0.64 至-0.17, p = 0.0006,I = 0%)和跌倒恐惧(SMD:-0.50,95% CI -0.79 至-0.22, p = 0.0006,I = 57%)方面有显著改善;与无运动对照组相比,太极拳在 SST(WMD:-2.20,95% CI -2.22 至-2.18, p < 0.00001)、平衡(SMD:9.85,95% CI 8.88-10.82, p < 0.00001)、舒张压(WMD:-7.00,95% CI -7.35 至-6.65, p < 0.00001)、简易精神状态检查(WMD:1.91,95% CI 1.73-2.09, p < 0.00001,I = 0%)、抑郁(SMD:-1.37,95% CI -1.91 至-0.83, p < 0.00001)和生活质量(SMD:10.72,95% CI 9.38-12.07, p < 0.00001)方面也有显著改善。在其余 4 项比较中,太极拳与对照组之间没有显著差异:身体肌肉质量(WMD:0.53,95% CI -0.18 至 1.24;P = 0.14;I = 0%)、握力(WMD:-0.06,95% CI -1.98 至 1.86;P = 0.95;I = 0%)、步态速度(WMD:0.05,95% CI -0.11 至 0.20;P = 0.55;I = 99%)和 SPPB(WMD:0.55,95% CI -0.04 至 1.14;P = 0.07)。通过荟萃回归分析,偏倚总结、太极拳指导员、太极拳动作和太极拳训练持续时间等变量与 30CST 或 TUGT 无显著关联。
我们的研究结果表明,患有衰弱或肌少症的患者练习太极拳可改善 30 秒椅子站立测试、起身行走测试的身体表现,减少跌倒和跌倒恐惧的次数。然而,太极拳组和对照组在肌肉质量、握力、步态速度或简短体能测试评分方面没有差异。与无运动对照组相比,太极拳组在坐站测试、平衡、舒张压、简易精神状态检查评分以及抑郁和生活质量评估方面有显著改善,而非与运动对照组相比。为了更全面地研究太极拳对肌少症和衰弱老年人的有效性,建议未来的研究采用标准化的太极拳训练方案,并详细描述研究设计。